Fresenius Kabi AG Overview
Company Headquarters: Hessen, Germany
Founded: 1999
Workforce: ~316,078
Company Working: Fresenius Kabi AG is a pharmaceutical company with a wide portfolio that includes intravenously administered drugs, infusion therapy, clinical nutrition, medical devices, and transfusion technology. Its product portfolio also comprises a comprehensive range of infusion therapies, I.V. generic drugs, clinical nutrition products, and the medical devices for administering these products. Within transfusion technologies, Fresenius Kabi provides products for gathering and managing blood components and for the therapeutic treatment of patient blood by apheresis systems. They have a production network that spans around 70 production sites, including compounding centers in Europe, North America, Latin America, Asia-Pacific, and Africa.
Strategy
Fresenius Kabi AG is focused on building a portfolio of medical foods to address the growing demand from hospitals and outpatient facilities and promote safety and convenience by using its innovative freeflex bag and port design. Its strategy is to use science-based innovation to deliver better medical food outcomes to customers. It aims to lead the growing healthcare sector by winning new patents and developing high-quality technologies.
